60 Degrees Pharma

05/29/2026

Over the past several years, Lyme disease has seen meaningful progress. That means more recognition, more research, and updated estimates that better reflect its impact.

It shows how quickly understanding can evolve when attention increases.

The question now is whether babesiosis will follow a similar path, and what it will take to get there.

Closing that gap is a big part of what our clinical trial is working toward.

Find out more about our clinical trials: https://60degreespharma.com/infectious-diseases/babesiosis/

05/28/2026

Reported cases only tell part of the story.

As Dr. Dow explains, available data suggests there could be a significant gap between reported babesiosis cases and actual prevalence.

When you factor in co-infection rates with Lyme disease, the true number of cases may be much higher than current estimates reflect.

Learn more about this undercount: https://investors.60degreespharma.com/news-releases/news-release-details/babesiosis-incidence-us-10x-higher-cdc-estimates-according

05/27/2026

Research is continuing to challenge assumptions about infection.

From persistent symptoms to long-term health effects, emerging data suggests the story may not always end when the acute phase does.

Understanding that shift is key to determining where the science goes next.

Find out more about the work we’re doing in this space: https://60degreespharma.com/infectious-diseases/babesiosis/

05/25/2026

In areas where research is limited, progress depends on building that foundation.

Clinical trials don’t just generate data –– they help define what’s measurable, what’s understood, and what comes next.

We’re honored to be moving this research ahead with our B-FREE clinical trial.

Read more about ongoing clinical trial efforts: https://60degreespharma.com/infectious-diseases/babesiosis/

05/21/2026

Babesia isn’t a single organism. It’s a group of parasites with different species, geographic patterns, and clinical implications.

Swipe to explore three of the most common types of Babesia →

Explore current clinical studies in babesiosis: https://60degreespharma.com/infectious-diseases/babesiosis/

05/19/2026

Tick exposure isn’t limited to remote trails or wooded areas.

They’re increasingly found in everyday environments – places you might move through without thinking twice. Sidewalks, parks, even your backyard.

As tick activity expands, awareness has to expand with it. Practice tick prevention all season (and all year!) long.

Find out more about the work we’re doing in this space: https://60degreespharma.com/infectious-diseases/babesiosis/

05/18/2026

This study isn’t just focused on treatment, it’s also looking closely at diagnostics.

By using multiple testing methods, the goal is to confirm infection using FDA-aligned standards, while evaluating how well existing diagnostics perform.

This kind of validation could help improve how babesiosis is detected and monitored in the future.

Link in bio to find out more: https://60degreespharma.com/infectious-diseases/babesiosis/

05/14/2026

Babesiosis can affect more than you’d expect.

Because it targets red blood cells, it can disrupt how oxygen moves through the body, which means the effects aren’t limited to one system.

Symptoms like fatigue, air hunger, and brain fog can all show up together, and not always in a way that clearly points to the underlying infection.

Learn more about ongoing babesiosis clinical research: https://60degreespharma.com/infectious-diseases/babesiosis/

05/13/2026

Reported case counts are only part of the story.

Lyme disease was once reported at a fraction of its estimated prevalence before surveillance methods improved.

As babesiosis cases continue to rise, it raises a familiar question about how much current data is capturing – and more importantly – how much may still be unaccounted for.

Learn more about what we’re seeing around babesiosis case numbers: https://investors.60degreespharma.com/news-releases/news-release-details/babesiosis-incidence-us-10x-higher-cdc-estimates-according

05/12/2026

Such important information from Global Lyme Alliance

Emergency room visits for tick bites have climbed to the highest levels for this time of year since 2017.